Pacemaker Therapy for Prevention of Syncope in Patients With Recurrent Severe Vasovagal Syncope

Abstract

In this double-blind randomized trial, pacing therapy did not reduce the risk of recurrent syncope in patients with vasovagal syncope. Because of the weak evidence of efficacy of pacemaker therapy and the risk of complications, pacemaker therapy should not be recommended as first-line therapy for patients with recurrent vasovagal syncope.

Keywords

MedicineVasovagal syncopeSyncope (phonology)Confidence intervalRandomizationRandomized controlled trialPlaceboAnesthesiaRelative riskCardiologySurgeryInternal medicine

Affiliated Institutions

McMaster University CA

Related Publications

Permanent Cardiac Pacing Versus Medical Treatment for the Prevention of Recurrent Vasovagal Syncope

Fabrizio Ammirati , Furio Colivicchi , Massimo Santini

Background —This clinical investigation was performed to compare the effects of permanent dual-chamber cardiac pacing with pharmacological therapy in patients with recurrent vas...

2001 Circulation 301 citations

Dual-Chamber Pacing in the Treatment of Neurally Mediated Tilt-Positive Cardioinhibitory Syncope

Richard Sutton , Michele Brignole , C. Menozzi +4 more

Background —This study was performed to compare implantation of a DDI pacemaker with rate hysteresis with no implant in respect to syncopal recurrences in patients with severe c...

2000 Circulation 405 citations

Symptoms associated with orthostatic hypotension in pure autonomic failure and multiple system atrophy

C.J. Mathias , R. Mallipeddi , Katharine Bleasdale-Barr

The symptoms caused by or relating to orthostatic hypotension (over 20 mmHg systolic blood pressure) were evaluated using a questionnaire in 72 patients with primary chronic aut...

1999 Journal of Neurology 171 citations

Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo

Dulce Obias-Manno , Allan H. Barker , Daniel Arensberg +7 more

There was an excess of deaths due to arrhythmia and deaths due to shock after acute recurrent myocardial infarction in patients treated with encainide or flecainide. Nonlethal e...

1991 New England Journal of Medicine 3193 citations

The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial

Bruce L. Wilkoff

Introduction: The devices used to prove the benefit of ICD therapy had only VVI pacing but most current ICD devices provide dual chamber pacing therapy. The DAVID trial sought t...

2003 Pacing and Clinical Electrophysiology 35 citations

Publication Info

Year: 2003
Type: article
Volume: 289
Issue: 17
Pages: 2224-2224
Citations: 491
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Pacemaker Therapy for Prevention of Syncope in Patients With Recurrent Severe Vasovagal Syncope

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

491

OpenAlex

Cite This

APA Style

                            
                                
                                    Stuart J. Connolly, 
                                
                                    Robert S. Sheldon, 
                                
                                    Kevin E. Thorpe
                                
                                et al.
                            
                            (2003). 
                            Pacemaker Therapy for Prevention of Syncope in Patients With Recurrent Severe Vasovagal Syncope. 
                            JAMA
                            , 289
                            (17)
                            , 2224-2224.
                            https://doi.org/10.1001/jama.289.17.2224
                        

Identifiers

DOI: 10.1001/jama.289.17.2224